|
RARS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.96210000000097E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.98280000091233E-08 |
| Normal-vs-Stage2 |
1.193550E-01 |
| Normal-vs-Stage3 |
1.446180E-01 |
| Normal-vs-Stage4 |
5.799000E-01 |
| Stage1-vs-Stage2 |
1.237400E-01 |
| Stage1-vs-Stage3 |
2.559400E-03 |
| Stage1-vs-Stage4 |
8.046900E-04 |
| Stage2-vs-Stage3 |
5.550800E-01 |
| Stage2-vs-Stage4 |
2.942000E-01 |
| Stage3-vs-Stage4 |
5.142600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.04979999999244E-05 |
| Normal-vs-AfricanAmerican |
6.207800E-01 |
| Normal-vs-Asian |
8.529800E-01 |
| Caucasian-vs-AfricanAmerican |
5.793800E-02 |
| Caucasian-vs-Asian |
4.310400E-01 |
| AfricanAmerican-vs-Asian |
9.714000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.984400E-03 |
| Normal-vs-Female |
3.54280000003371E-06 |
| Male-vs-Female |
4.582200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.234400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.208000E-04 |
| Normal-vs-Age(61-80Yrs) |
2.233700E-04 |
| Normal-vs-Age(81-100Yrs) |
5.287200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.652000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.485000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.715000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.053000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.201000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.052400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.8406999999776E-06 |
| Normal-vs-Grade 2 |
4.02470001770183E-09 |
| Normal-vs-Grade 3 |
6.642300E-02 |
| Normal-vs-Grade 4 |
4.173600E-01 |
| Grade 1-vs-Grade 2 |
2.133400E-01 |
| Grade 1-vs-Grade 3 |
1.647880E-02 |
| Grade 1-vs-Grade 4 |
9.610300E-04 |
| Grade 2-vs-Grade 3 |
5.76729999999248E-05 |
| Grade 2-vs-Grade 4 |
8.04729999970277E-07 |
| Grade 3-vs-Grade 4 |
3.429700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.81721304670646E-12 |
| Normal-vs-ccB subtype |
1.999760E-01 |
| ccA subtype-vs-ccB subtype |
1.24960000014163E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.60276999999764E-05 |
| Normal-vs-N1 |
6.376600E-01 |
| N0-vs-N1 |
4.001600E-02 |
|
|
